HDAC INHIBITOREN

European patent · EP2970139 · Deleted

Register entry

Publication number
EP2970139
Application number
EP14722448
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 14, 2014
Published
Jan 20, 2016
Granted
May 30, 2018
Deleted
Oct 25, 2022
Reason
Annual fee unpaid
IPC classes
C07D 231/56 (2006.01)
C07D 401/06 (2006.01)
A61K 31/416 (2006.01)
A61P 25/00 (2006.01)
Priority
US 201361800170 P 15.03.2013
US 201361863235 P 07.08.2013
PCT application
PCT/US2014/027633 14.03.2014
PCT publication
WO2014/143666 18.09.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 25, 2022

    Deleted, fee unpaid

    Published in Swissreg on 25.10.2022

  2. May 16, 2022

    Address changed

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich → RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 16.05.2022

  3. Aug 3, 2018

    Agent entered

    Representative
    RENTSCH PARTNER AG, Bellerivestrasse 203, Postfach, 8034 Zürich

    Published in Swissreg on 03.08.2018

  4. May 30, 2018

    Granted

    Published in Swissreg on 30.05.2018

Parties

Holder

Biomarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

105 Digital Drive, Novato, CA 94949, US

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventor

JACQUES, Vincent

Somerville, MA 02144, US

RUSCHE, James, R.

Framingham, MA 01702, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.